Rosen Law Firm & MiNK Therapeutics

Rosen Law Firm: Rosen Law Firm is a global investor rights law firm reminding purchasers of MiNK Therapeutics common stock about the lead plaintiff deadline for the class action lawsuit.

MiNK Therapeutics: MiNK Therapeutics is the primary defendant in multiple class action lawsuits alleging securities fraud due to misleading statements about the safety and commercial viability of its drug candidate, DCCR. The company's stock price has significantly declined following reports of safety concerns, a patient death, and disruptions in DCCR's launch.